This was July: -*we could call this the starting point. This is when he started Gleevec. He wasn't able to take Sprycel without his platelets and WBC crashing so he was off it more than on it.
For Test: MISCELLANEOUS(FEE basis)
Peripheral blood for bcr/abl for CML
Assay performed at reference lab LABCORP, sample sent 0720 11
B2A2 TRANSCRIPT: 93.172 %
B3A2 TRANSCRIPT
<0.001 %
(sensitivity limit of assay)
E1A2 TRANSCRIPT
<0.001 %
(sensitivity limit of assay)
INTERPRETATION:
The quantitative RT-PCR assay is positive for the b2a2 (p210)
fusion gene transcript found in chronic myelogenous leukemia.
Decembers test: -taking gleevec
Assay performed at reference lab LABCORP, sample sent 12-1-11
TEST RESULTS LIMITS
BCR-ABL1, CML/ALL, PCR,Quant
b2a2 transcript 6.551 %
b3a2 transcript <0.001 %
(Sensitivity limit of assay)
e1a2 transcript <0.001 %
(Sensitivity limit of assay)
Interpretation:
The quantitative RT-PCR assay is positive for b2a2 (p210) fusion
gene transcript found in chronic myelogenous leukemia.
For Test: MISCELLANEOUS(FEE basis)
Peripheral Blood for PCR for BCR/ABL for CML
He's having his 3rd test on Friday, and we'll get those results hopefully on the 1st. Would a 3 log reduction from 6.551% be 0.006551%? Am I understanding that correctly? I just want to know what I should be "hoping" for. Is it a 3 log reduction every 3 months?
Thanks!